indoramin and prazosin
indoramin has been researched along with prazosin in 52 studies
Research
Studies (52)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (67.31) | 18.7374 |
| 1990's | 9 (17.31) | 18.2507 |
| 2000's | 5 (9.62) | 29.6817 |
| 2010's | 3 (5.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Baudy, R; Jirkovsky, I; Oshiro, G; Santroch, G | 1 |
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Bitter, SM; Caroon, JM; Clark, RD; Michel, AD; Okada, MD; Repke, DB; Strosberg, AM; Whiting, RL | 1 |
| Caroon, JM; Clark, RD; Kluge, AF; Lee, CH; Strosberg, AM | 1 |
| Caroon, JM; Clark, RD; Kluge, AF; Michel, AD; Nelson, JT; Strosberg, AM; Unger, SH; Whiting, RL | 1 |
| Bondinell, WE; Hieble, JP; Ruffolo, RR | 1 |
| Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
| Chang, DJ; Clarke, DE; Daniels, DV; Ford, AP; Gever, JR; Jasper, JR; Lesnick, JD | 1 |
| Chang, DJ; Clarke, DE; Daniels, DV; Ford, AP; Gever, JR; Jasper, JR; Kava, MS; Lesnick, JD; Meloy, TD; Stepan, G; Williams, TJ | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Frost, GW; Graham, RM; MacCarthy, EP; Stokes, GS | 1 |
| Graham, RM; Oates, HF; Stokes, GS | 1 |
| Gagało, I; Szreder, Z | 1 |
| Harron, DW | 1 |
| Strandhoy, JW | 1 |
| Overlack, A; Stumpe, KO | 1 |
| Solomon, R | 1 |
| Shanks, RG | 1 |
| Rietbrock, N; Woodcock, BG | 1 |
| Shebuski, RJ; Zimmerman, BG | 1 |
| Offermeier, J; Rossouw, J; van Rooyen, JM | 1 |
| Sheridan, DJ | 1 |
| Gentleman, SM; Hedley, D; McQueen, AS; Pertwee, RG | 1 |
| Bache, RJ; Dai, XZ; Homans, DC; Schwartz, JS | 1 |
| Dollery, CT; Warren, JB | 1 |
| Good, AP; Leier, CV; Unverferth, DV | 1 |
| Pierce, V; Shepperson, NB; Todd, MH; Waterfall, JF | 1 |
| Ramage, AG | 2 |
| Aliperta, A; Catena, E; Giordano, L; Lampa, E; Marmo, E; Perna, D; Rossi, F | 1 |
| Dean, RR; Waterbury, LD | 1 |
| Marxer, A; Schier, O | 1 |
| Fox, J; Pheysey, J; Wood, MD; Wyllie, MG | 1 |
| Reid, JL; Rubin, PC | 1 |
| Anand, MP | 1 |
| Abrams, SM; Turner, P | 1 |
| Birkenhäger, WH; De Leeuw, PW | 1 |
| Graham, RM | 1 |
| Drayer, JI; Weber, MA | 1 |
| Jarrott, B; Louis, WJ; Summers, RJ | 1 |
| Bricola, A; Jurkiewicz, A; Jurkiewicz, NH | 1 |
| Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I | 1 |
| Hussain, MB; Marshall, I | 2 |
| Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
| Clifford, GM; Farmer, RD | 1 |
Reviews
12 review(s) available for indoramin and prazosin
| Article | Year |
|---|---|
Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.
Topics: Animals; Humans; Molecular Biology; Molecular Structure; Radioligand Assay; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1995 |
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Humans; Hypertension; Indoramin; Labetalol; Piperazines; Prazosin | 1988 |
Antihypertensive agents 1969-1980.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Ergolines; Fusaric Acid; Guanidines; Humans; Hydralazine; Indoramin; Methyldopa; Minoxidil; Nifedipine; Piperazines; Prazosin; Prostaglandins | 1981 |
Hypertension--drug management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Diazoxide; Humans; Hypertension; Indoramin; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin; Sympatholytics; Vasodilator Agents; Verapamil | 1982 |
The role of alpha-adrenoceptor blockade in the treatment of hypertension.
Topics: Adrenergic alpha-Antagonists; Humans; Hypertension; Indoramin; Prazosin; Receptors, Adrenergic, alpha | 1983 |
Alpha-adrenergic blockade in the treatment of essential hypertension.
Topics: Adrenergic alpha-Antagonists; Biomechanical Phenomena; Hemodynamics; Humans; Hypertension; Indoramin; Labetalol; Phenoxybenzamine; Prazosin; Receptors, Adrenergic, alpha | 1983 |
Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents.
Topics: Adrenergic alpha-Antagonists; Ethanolamines; Humans; Hypertension; Indoramin; Labetalol; Prazosin; Receptors, Adrenergic, alpha; Vascular Resistance | 1984 |
Central and peripheral blockade of the sympathetic nervous system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Guanabenz; Humans; Hypertension; Indoramin; Labetalol; Methyldopa; Prazosin; Quinazolines; Reserpine; Sympathetic Nervous System; Sympatholytics | 1984 |
[Alpha blockers in the treatment of benign hyperplasia of the prostate].
Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 1997 |
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
Medical therapy for benign prostatic hyperplasia: a review of the literature.
Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2000 |
Trials
4 trial(s) available for indoramin and prazosin
| Article | Year |
|---|---|
Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Indoramin; Male; Middle Aged; Prazosin; Pulse; Quinazolines | 1979 |
Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Cholesterol; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Indoles; Indoramin; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Prazosin | 1986 |
Antihypertensive effects of indoramin and prazosin in combination with hydrochlorothiazide.
Topics: Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Indoles; Indoramin; Prazosin | 1986 |
Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Clonidine; Extremities; Female; Heart Failure; Hemodynamics; Humans; Indoramin; Liver; Liver Circulation; Male; Middle Aged; Prazosin; Regional Blood Flow; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1988 |
Other Studies
36 other study(ies) available for indoramin and prazosin
| Article | Year |
|---|---|
Octahydropyrazino[2',3':3,4]pyrido[1,2-a]indoles. A new class of potent antihypertensive agents.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Epinephrine; Heart Rate; Indicators and Reagents; Indoles; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Pyrazines; Pyridines; Rats; Rats, Inbred SHR; Spectrophotometry; Structure-Activity Relationship | 1987 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Antihypertensive 9-substituted 1-oxa-4,9-diazaspiro[5.5]undecan-3-ones.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Cerebral Cortex; Norepinephrine; Prazosin; Rats; Spiro Compounds; Structure-Activity Relationship; Yohimbine | 1983 |
Synthesis and antihypertensive activity of a series of spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one]s.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Antihypertensive Agents; Aorta; Drug Evaluation, Preclinical; In Vitro Techniques; Magnetic Resonance Spectroscopy; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Oxazoles; Quinolizines; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1983 |
Synthesis and antihypertensive activity of a series of 8-substituted 1-oxa-3,8-diazaspiro[4.5]decan-2-ones.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Chemical Phenomena; Chemistry; Dogs; Epinephrine; Indoramin; Male; Norepinephrine; Oxazoles; Phentolamine; Phenylephrine; Rats; Spiro Compounds; Structure-Activity Relationship | 1981 |
Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.
Topics: Adrenergic Agents; Animals; CHO Cells; Cloning, Molecular; Cricetinae; Humans; Inositol Phosphates; Radioligand Assay; Receptors, Adrenergic, alpha-1; Recombinant Proteins | 1997 |
Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies.
Topics: Adrenergic alpha-Agonists; Animals; CHO Cells; Cloning, Organism; Cricetinae; Humans; In Vitro Techniques; Inositol Phosphates; Protein Isoforms; Receptors, Adrenergic, alpha-1; Recombinant Proteins | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Mechanism of the hypotensive action of prazosin.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diazoxide; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; Heart Rate; Hydralazine; Indoramin; Norepinephrine; Pentolinium Tartrate; Phentolamine; Prazosin; Quinazolines; Rats | 1977 |
The effect of doxazosin, urapidil and indoramin pretreatment on fever produced by E. coli lipopolysaccharide in rabbits.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature Regulation; Doxazosin; Escherichia coli; Female; Fever; Indoramin; Lipopolysaccharides; Male; Piperazines; Prazosin; Rabbits | 1991 |
Experimental evidence for the antiarrhythmic action of indoramin.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cats; Coronary Vessels; Electrocardiography; Guinea Pigs; Heart; Heart Rate; Indoles; Indoramin; Mexiletine; Myocardial Contraction; Prazosin; Rats; Sotalol | 1986 |
Comparison of the renal effects of indoramin and prazosin.
Topics: Animals; Blood Pressure; Dogs; Glomerular Filtration Rate; Heart Rate; Indoles; Indoramin; Intracranial Pressure; Kidney; Kinetics; Phenylephrine; Potassium; Prazosin; Sodium | 1986 |
The clinical pharmacology of indoramin.
Topics: Blood Pressure; Heart Rate; Humans; Hypertension; Indoles; Indoramin; Kinetics; Norepinephrine; Phenoxybenzamine; Phenylephrine; Posture; Prazosin; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1986 |
[Circadian rise of blood pressure and combined alpha-beta adrenoceptor blockade].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Circadian Rhythm; Cold Temperature; Drug Therapy, Combination; Humans; Hypertension; Indoramin; Labetalol; Prazosin; Propranolol | 1985 |
Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Brain; Dogs; Female; Heart Rate; Indoramin; Male; Phenylephrine; Piperazines; Prazosin; Pressoreceptors; Quinazolines; Reflex; Vascular Resistance | 1985 |
The alpha 1- and alpha 2-adrenoceptor selectivity of drugs with potential effects on blood pressure--a radioligand-binding study.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Imidazoles; Indoramin; Prazosin; Radioligand Assay; Rats; Receptors, Adrenergic, alpha | 1986 |
Alpha adrenoceptors and arrhythmias.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Catecholamines; Coronary Disease; Guinea Pigs; Humans; Indoramin; Methoxamine; Myocardial Contraction; Phentolamine; Prazosin; Receptors, Adrenergic, alpha; Stimulation, Chemical; Swine | 1986 |
The hypothermic response of mice to delta-9-tetrahydrocannabinol is enhanced by chlorpromazine, thioxanthenes, alpha-adrenoceptor antagonists and pentolinium but not by SCH 23390 or sulpiride.
Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Benzazepines; Body Temperature; Chlorpromazine; Dronabinol; Drug Synergism; Hypothalamus, Anterior; Indoramin; Injections; Male; Mice; Pentolinium Tartrate; Phentolamine; Prazosin; Preoptic Area; Sulpiride; Thioxanthenes | 1988 |
Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise.
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Circulation; Dogs; Hemodynamics; Indoles; Indoramin; Oxygen Consumption; Physical Exertion; Prazosin; Regional Blood Flow | 1988 |
Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.
Topics: Animals; Blood Pressure; Female; Heart Rate; Indoles; Indoramin; Injections, Intravenous; Injections, Intraventricular; Pharmaceutical Vehicles; Prazosin; Rats; Rats, Inbred Strains; Sympathetic Nervous System | 1986 |
Evidence for a central sympathoinhibitory action of prazosin and indoramin.
Topics: Animals; Blood Pressure; Carotid Sinus; Cats; Heart Rate; Indoles; Indoramin; Male; Prazosin; Regional Blood Flow; Sympathetic Nervous System; Sympatholytics; Time Factors; Vagotomy | 1986 |
The effect of prazosin, indoramin and phentolamine on sympathetic nerve activity.
Topics: Animals; Blood Pressure; Cats; Heart Rate; Indoles; Indoramin; Male; Phentolamine; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Sympathetic Nervous System | 1984 |
A study on the effects of some drugs on DOCA induced hypertension in the rat.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Cardiomegaly; Desoxycorticosterone; Diuretics; Hypertension; Indoramin; Male; Metoprolol; Prazosin; Pulmonary Artery; Rats; Verapamil | 1980 |
Effects of alpha agonists and alpha blocking drugs on mouse plasma renin activity.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Drug Interactions; Heart Rate; Indoramin; Isoproterenol; Male; Mecamylamine; Methoxamine; Mice; Phenoxybenzamine; Prazosin; Renin | 1980 |
Indoramin.
Topics: Humans; Hypertension; Indoles; Indoramin; Prazosin | 1981 |
Modulation of central noradrenaline release by postsynaptic receptors.
Topics: alpha-Methyltyrosine; Animals; Brain; Cerebral Cortex; In Vitro Techniques; Indoramin; Methyltyrosines; Norepinephrine; Prazosin; Rats; Receptors, Adrenergic; Synapses; Synaptosomes; Time Factors; Yohimbine | 1982 |
Alpha-blockers and converting enzyme inhibitors.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension; Indoramin; Kinetics; Labetalol; Prazosin | 1983 |
Selectivity of a series of clonidine-like drugs for alpha 1 and alpha 2 adrenoceptors in rat brain.
Topics: Aniline Compounds; Animals; Cerebral Cortex; Clonidine; Guanabenz; Guanfacine; Guanidines; Imidazoles; In Vitro Techniques; Indoramin; Naphazoline; Oxazoles; Phenylacetates; Prazosin; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Thiophenes; Toluidines | 1980 |
Functional study of the excitatory alpha-adrenoceptor in guinea pig ileum, in relation to the hypothesis of an atypical receptor.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Dioxanes; Epinephrine; Guinea Pigs; Ileum; Indoramin; Models, Biological; Muscle Contraction; Norepinephrine; Phenylephrine; Piperoxan; Prazosin; Receptors, Adrenergic, alpha | 1997 |
Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Binding, Competitive; Dioxanes; Dioxins; Dose-Response Relationship, Drug; In Vitro Techniques; Indoles; Indoramin; Isometric Contraction; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Oxathiins; Phenylephrine; Piperazines; Prazosin; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Spiro Compounds; Vasoconstrictor Agents | 1997 |
Alpha(1)-adrenoceptor subtypes mediating contractions of the rat mesenteric artery.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Dioxanes; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; In Vitro Techniques; Indoles; Indoramin; Male; Mesenteric Arteries; Methoxamine; Oxathiins; Phenylephrine; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Vasoconstriction; Vasoconstrictor Agents | 2000 |